Results 81 to 90 of about 3,350 (181)

Molecular Classification in a Cohort of Occupational Dermatological Patients: Diagnostic Results and Course of Ability to Work and Sick Leave Over Two Years

Acta Dermato-Venereologica
Hand eczema is the most common occupational skin disease (OSD), often leading to sick leave or job termination. Standard diagnostic procedures are often ambiguous. Molecular classification has been described to improve differentiation between eczema and
Philipp Bentz, Kilian Eyerich, Christoph Skudlik, Claudia Schröder-Kraft, Harald Löffler, Claudia Pföhler, Nicolas Leitz, Karisa Thölken, Elke Weisshaar   +8 more
doaj   +1 more source

Skin manifestations in diabetes—what is new?

Frontiers in Medicine
Diabetes is a chronic disease with a continuously increasing prevalence worldwide. Chronic hyperglycaemia results from elevated blood glucose levels due to disturbed insulin secretion and/or action.
Natalia Dorf, Mateusz Maciejczyk
doaj   +1 more source

Practical dermatology [PDF]

, 2006
DERMATOLOGYSKIN DISEASESКОЖНЫЕ БОЛЕЗНИМЕТОДИЧЕСКИЕ РЕКОМЕНДАЦИИПРАКТИЧЕСКАЯ ДЕРМАТОЛОГИЯRecommendations include tests, clinical tasks and practical skills in dermatology that are used as during practical classes as at the ...
Adaskevich, V. P., Katina, M. A., Valles-Kazlouskaya, V. V.   +2 more
core  

Tinea pedis: diagnosis and management

, 2004
Tinea pedis is one of the most commonly encountered foot infections. The fact that in most cases it is easily treatable yet still prevalent in the general population suggests it is often undiagnosed or remains untreated by health care professionals and ...
Bristow, I.R.
core  

AMERICAN CUTANEOUS LEISHMANIASIS AND CUTANEOUS MYIASIS: CONVERGENCE OF TWO TROPICAL DISEASES

Brazilian Journal of Infectious Diseases
Introduction: American Cutaneous Leishmaniasis (ACL) is an infectious disease caused by protozoa of the genus Leishmania, transmitted by the bite of infected sand flies.
Luís Arthur Brasil Gadelha Farias, Lia Girão Bezerra, Gabriel Chagas Vieira, Yuri Alves de Arruda Bezerra, Glaura Fernandes Teixeira de Alcântara   +4 more
doaj   +1 more source

IMPACT OF HYPERKERATOTIC PALMOPLANTAR DERMATOSES ON DERMATOLOGY LIFE QUALITY INDEX, IN A TERTIARY CARE CENTRE IN EASTERN INDIA: A CROSS-SECTIONAL STUDY. [PDF]

Background:  Palmoplantar dermatoses viz., palmoplantar psoriasis (PPP), hyperkeratotic hand foot eczema (HHFE), and palmoplantar keratoderma (PPK) are the common concern in dermatology as being chronic nature of the dermatoses.
Bhunia, Deblina, Raut, Poonam, Saha, Pranab Kumar, Singh, Priyanka   +3 more
core   +2 more sources

Drug Allergy with Cutaneous Manifestations. Diagnostic Approach [PDF]

, 2012
As reacções adversas a fármacos (RAF) representam um problema frequente na prática clínica. A alergia a fármacos resulta de mecanismos de hipersensibilidade imunológica e representa 6-10% do total de RAF.
Amaro, C, Antunes, J, Brás, S, Leiria-Pinto, P, Prates, S   +4 more
core  

Diccionario Podológico Español-Ingles Términos podológicos de uso común en el Grado de Podología (Cuaderno de ayuda para el alumno) [PDF]

, 2017
Diccionario con terminos utilizados en el ambito de la podologia tanto en ingles como en español, y su definicion en ambos idiomas.Se pretende sea un documento de uso dentro de las asignaturas del Grado de Podologia para facilitar uso de terminos en ...
Cervera-Marin, Jose Antonio, García-Payá, Irene, Gijón-Noguerón, Gabriel, Ortega-Avila, Ana Belen   +3 more
core  

Progress [PDF]

, 1989
Magazine reporting on the activities and programs of the University Hospital at Boston University Medical ...
Office of Publication Services, Boston University Medical Center
core  

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015 [PDF]

, 2016
Abel EA, Berg M, Berg M, Bhatnagar A, Bilsland D, Bjellerup M, Calzavara‐Pinton PG, Chen X, Cox AJ, Deleu H, Diffey BL, Freeman K, George SA, Gilchrest BA, Grattan CE, Hannuksela M, Hönigsmann H, Jansén CT, Jansén CT, Jeanmougin M, Joint Formulary Committee, Kao CL, Kivanc MT, Lassus A, Leonard F, LeVine MJ, Lindelöf B, Maravić N, Margolis D, Marguery MC, Marsland AM, Mastalier U, Mathews‐Roth MM, McFadden N, McGeorge BC, Molin L, Morison WL, Neumann NJ, Norris PG, Park YM, Pirner K, Pothiawala SZ, Reymond JL, Roelandts R, Roelandts R, Roelandts R, Roenigk HH, Ros AM, Ros AM, Rosén K, Rosén K, Rosén K, Rübben A, Sheehan‐Dare RA, Stadler R, Stern RS, Takashima A, Tegner E, Tegner E, Thomsen K, Turjanmaa K, Viander M, Vázquez‐López F, Weelden H, Wennersten G, Wilkinson JD   +65 more
core   +2 more sources